Opioid Attractiveness Scale Development
Author Information
Author(s): Stephen F. Butler, Christine Benoit, Simon H. Budman, Kathrine C. Fernandez, Cynthia McCormick, Synne Wing Venuti, Nathaniel Katz
Primary Institution: Inflexxion, Inc.
Hypothesis
The study aims to develop a scale to measure the attractiveness of prescription opioids to potential abusers.
Conclusion
The Opioid Attractiveness Scale (OAS) is a valid and reliable tool for assessing the attractiveness of opioid products to potential abusers.
Supporting Evidence
- The OAS demonstrated excellent internal consistency with Cronbach's α ranging from 0.85 to 0.94.
- Drug rankings based on OAS scores achieved good inter-rater agreement with Kendall's W of 0.37.
- The OAS differentiated attractiveness among 14 selected pharmaceutical opioid products.
Takeaway
Researchers created a scale to see which prescription opioids are most appealing to people who might misuse them, helping to understand and manage risks.
Methodology
The study used Concept Mapping to define attractiveness and developed a 17-item scale, which was tested for validity and reliability with substance abusers and experts.
Potential Biases
Participants may not have been entirely truthful about their experiences with certain drugs.
Limitations
The study may have limitations due to potential biases in self-reported data from substance abusers.
Participant Demographics
{"age_mean":39.08,"gender_distribution":{"male":50,"female":50},"race_distribution":{"White":61,"African-American":8,"Hispanic":26,"Other":5},"residence":{"urban":74,"rural":26}}
Statistical Information
P-Value
p = 0.002
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website